Law Street
Cut through the clutter and focus on the facts with Law Street Media. Established in 2013 by a recognized journalist and a group of dynamic young entrepreneurs, Law Street is crafted for Millennials, by Millennials. Our mission is to educate and inform, going beyond surface-level news to explore the deeper significance of issues that matter to our generation. We speak from experience, understanding the challenges and realities we all face. Law Street is your source for Law & Policy tailored for today's youth.
Outlet metrics
Global
#1287051
United States
#510904
Law and Government/Law and Government
#1122
Articles
-
1 week ago |
lawstreetmedia.com | David Nayer
FOIAengine: Multiple Hedge Funds Seeking Inspection ReportsLeading medical device manufacturer Insulet Corporation’s stock price (NASDAQ: PODD) is on a roll. But that hasn’t stopped leading financial firms from monitoring the company’s Food and Drug Administration plant inspections to learn of any bad news that might slow its growth.
-
2 weeks ago |
lawstreetmedia.com | David Nayer
Alternative asset management firm TPG announced plans to acquire Sabre Corporation’s Hospitality Solutions business for $1.1 billion. The all-cash deal is projected to net Sabre $960 million, after accounting for taxes and fees, which will be used primarily to pay down debt. “Hospitality Solutions provides software and solutions to more than 40 percent of the world’s leading hotel brands,” according to the deal’s press release.
-
2 weeks ago |
lawstreetmedia.com | David Nayer
In 1995, Congress passed the Private Securities Litigation Reform Act, or PSLRA. The law was designed to stem the tide of allegedly frivolous securities lawsuits. Such lawsuits are filed under Rule 10(b) of the Securities Exchange Act of 1934, and generally allege that the plaintiff’s investment holdings were devalued, via a decrease in stock price, by the misstatements or omissions of the defendant corporation. The PSLRA raises the pleading requirements for these lawsuits.
-
3 weeks ago |
lawstreetmedia.com | David Nayer
Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800 million. The all cash deal includes a contingent value right providing for an additional payment of $7.00 per share to Regulus shareholders, contingent upon the achievement of a milestone with respect to regulatory approval of the company’s farabursen product, which aims to treat autosomal dominant polycystic kidney disease.
-
3 weeks ago |
lawstreetmedia.com | David Nayer
FOIAengine Tracks the High Cost of Getting Even, and the RewardsUntil six weeks ago, Jason Galanis was Inmate 80739-198 at the federal prison in Montgomery, Alabama, sentenced to almost 16 years confinement after admitting to a wild scheme in which he swindled tens of millions of dollars from the Oglala Sioux tribe and its pension fund.
Law Street journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://lawstreetmedia.comTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →